Parkview Professional Programs, INC.

Parkview Professional Programs, INC. was paid $309K by Medicaid between Jan 2018 and Nov 2024, across 42 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 15% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Indiana

Rank by total paid#19 of 66

Median peer was paid$53K

This provider vs. median5.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	23,589	$80K
2019	17,719	$65K
2020	4,088	$30K
2021	4,826	$74K
2022	3,785	$27K
2023	4,005	$24K
2024incomplete	2,656	$10K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	15%	721	625	$48K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	15%	9,017	5,120	$47K
80053	Comprehensive metabolic panel	9.1%	4,083	2,491	$28K
80048	Basic metabolic panel (calcium, ionized)	6.9%	4,349	2,708	$21K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	4.5%	663	583	$14K
80061	Lipid panel	4.1%	1,405	1,183	$13K
36415	Collection of venous blood by venipuncture	3.7%	8,320	4,303	$11K
87077		3.7%	1,786	1,411	$11K
87086	Culture, bacterial; quantitative colony count, urine	3.6%	2,627	2,028	$11K
83036	Hemoglobin; glycosylated (A1C)	3.0%	1,447	1,231	$9K
87186		2.8%	1,484	1,193	$9K
82565		2.7%	2,456	1,329	$8K

30 more codes

82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.6%	480	$8K
84443	Thyroid stimulating hormone (TSH)	2.5%	913	$8K
84520		2.2%	2,072	$7K
85027		1.7%	1,307	$5K
80076		1.6%	812	$5K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	1.6%	8,043	$5K
85610		1.5%	1,469	$5K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.4%	156	$4K
81001		1.4%	2,462	$4K
80051		1.3%	1,169	$4K
86140		1.1%	769	$3K
83735		<1%	721	$3K
80050	General health panel	<1%	84	$3K
80164		<1%	275	$3K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	50	$3K
86803		<1%	157	$2K
82140		<1%	111	$1K
85652		<1%	545	$1K
87653		<1%	62	$1K
87070		<1%	196	$984.88
83880		<1%	66	$753.13
87205		<1%	180	$463.76
82607		<1%	29	$278.12
84480		<1%	23	$228.31
83540		<1%	44	$140.16
84436		<1%	23	$116.79
87081		<1%	29	$102.23
83550		<1%	14	$63.85
81003		<1%	33	$43.33
82947		<1%	16	$33.25

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBROWNING, MIKE (EXECUTIVE VP -- CFO)

Parent organizationPARKVIEW PROFESSIONAL PROGRAMS, INC.